Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
European Archives of Psychiatry and Clinical Neuroscience|October 31, 2009
Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatmentStefan Klingberg, Andreas Wittorf, Jutta Herrlich, et al.Schizophrenia Bulletin|August 24, 2011
Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES studyStefan Klingberg, Wolfgang Wölwer, Corinna Engel, et al.Journal of Clinical Psychopharmacology|September 4, 2010
Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSFGeorg Nikisch, Pierre Baumann, Georg Wiedemann, et al.The Journal of Nervous and Mental Disease|July 5, 2012
Adverse effects of cognitive behavioral therapy and cognitive remediation in schizophrenia: results of the treatment of negative symptoms studyStefan Klingberg, Jutta Herrlich, Georg Wiedemann, et al.Journal of Clinical Nursing|November 9, 2012
Cultural adaptation and psychometric properties of the family questionnaire in a Brazilian sample of relatives of schizophrenia outpatientsAna C G Zanetti, Georg Wiedemann, Rosana A S Dantas, et al.Journal of Psychopharmacology (Oxford, England)|December 15, 2010
Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot studyGeorg Nikisch, Pierre Baumann, Beatrice Oneda, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|February 10, 2009
The influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophreniaAndreas Wittorf, Ute Jakobi, Andreas Bechdolf, et al.Journal of Psychiatric Research|February 24, 2010
Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapineGeorg Nikisch, Pierre Baumann, Bernhard Kiessling, et al.Psychotherapie, Psychosomatik, Medizinische Psychologie|April 8, 2009
[Research into the feasibility of cognitive behavioural therapy in the treatment of psychotic disorders]Stefan Klingberg, Andreas Wittorf, Andreas Bechdolf, et al.Psychiatry Research|September 3, 2013
Associations between therapy skills and patient experiences of change processes in cognitive behavioral therapy for psychosisAndreas Wittorf, Ute E Jakobi-Malterre, Silke Beulen, et al.Pageof 4